ATE509095T1 - Menschliches ex-vivo-hautmodell - Google Patents

Menschliches ex-vivo-hautmodell

Info

Publication number
ATE509095T1
ATE509095T1 AT08157036T AT08157036T ATE509095T1 AT E509095 T1 ATE509095 T1 AT E509095T1 AT 08157036 T AT08157036 T AT 08157036T AT 08157036 T AT08157036 T AT 08157036T AT E509095 T1 ATE509095 T1 AT E509095T1
Authority
AT
Austria
Prior art keywords
human
skin model
vivo skin
vivo
pharmacological
Prior art date
Application number
AT08157036T
Other languages
English (en)
Inventor
Gabriele Vielhaber
Paolo Pertile
Michele Massironi
Original Assignee
Symrise Ag
Cutech S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39761097&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE509095(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Symrise Ag, Cutech S R L filed Critical Symrise Ag
Application granted granted Critical
Publication of ATE509095T1 publication Critical patent/ATE509095T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
AT08157036T 2008-05-28 2008-05-28 Menschliches ex-vivo-hautmodell ATE509095T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08157036A EP2019316B1 (de) 2008-05-28 2008-05-28 Menschliches ex-vivo-Hautmodell

Publications (1)

Publication Number Publication Date
ATE509095T1 true ATE509095T1 (de) 2011-05-15

Family

ID=39761097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08157036T ATE509095T1 (de) 2008-05-28 2008-05-28 Menschliches ex-vivo-hautmodell

Country Status (3)

Country Link
US (1) US8278068B2 (de)
EP (1) EP2019316B1 (de)
AT (1) ATE509095T1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8548557B2 (en) * 2010-08-12 2013-10-01 Covidien Lp Medical electrodes
GB2485816A (en) * 2010-11-25 2012-05-30 Alcyomics Ltd In vitro model for the prediction of immunogenicity, hypersensitivity or allergenicity
US20120283112A1 (en) 2011-02-22 2012-11-08 The Procter & Gamble Company Systems and Methods for Identifying Cosmetic Agents for Skin Care Compositions
EP2691539B1 (de) 2011-03-31 2018-04-25 The Procter and Gamble Company Verfahren zur identifizierung und evaluierung von haut-wirkstoffen wirksam bei der behandlung von schuppen
EP2795319B1 (de) 2011-12-20 2017-11-29 The Procter and Gamble Company Verfahren zur entnahme von proben der menschlichen haut sowie modelle zur beurteilung der tönungsspezifischen vorteile von mitteln
ITCA20120004A1 (it) * 2012-03-30 2012-06-29 Abdelkrim Harchi Unico reattivo disidratante e diafanizzante per istologia e citologia non nocivo e non tossico, biodegradabile 88%, a bassa volatilita'
FR2990106B1 (fr) * 2012-05-03 2014-05-09 Genoskin Systeme permettant la maintenance en survie et le transport de biospsies de peau et ses applications
EP2859486A2 (de) 2012-06-06 2015-04-15 The Procter & Gamble Company Systeme und verfahren zur identifizierung kosmetischer wirkstoffe für haar-/kopfhautpflegezusammensetzungen
US9593363B2 (en) 2012-06-18 2017-03-14 The Procter & Gamble Company Methods and models for assessing anti-aging benefits of agents
US9804152B1 (en) 2012-08-15 2017-10-31 The Procter & Gamble Company Human ex vivo skin model and its use in methods of identifying modulators of skin inflammation
US9362615B2 (en) 2012-10-25 2016-06-07 Raytheon Company Multi-bandpass, dual-polarization radome with embedded gridded structures
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
MX2015011771A (es) 2013-03-08 2016-12-07 Axiom Foods Inc Suplemento de proteínas de arroz y métodos de uso de este.
US9005674B1 (en) 2013-07-01 2015-04-14 The Procter & Gamble Company Method of improving the appearance of aging skin
US9808011B2 (en) 2014-12-15 2017-11-07 Biovectra Inc. Pentacyclic triterpene compounds and uses thereof
FR3030572A1 (fr) 2014-12-18 2016-06-24 Galderma Res & Dev Modele de peau humaine et son utilisation pour evaluer ex vivo les effets dermatologiques, cosmetiques et/ou nutraceutiques de composes
WO2018089047A1 (en) * 2016-11-10 2018-05-17 Kimberly-Clark Worldwide, Inc. Three-dimensional aged skin model and method of creating the same
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
FR3071508B1 (fr) 2017-09-26 2022-07-29 Genoskin Modele ex vivo de peau humaine inflammee et ses utilisations pour le criblage de composes anti-inflammatoires

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3740186A1 (de) 1987-06-24 1989-01-05 Beiersdorf Ag Desodorierende und antimikrobielle zusammensetzung zur verwendung in kosmetischen oder topischen zubereitungen
DE3938140A1 (de) 1989-11-16 1991-08-08 Beiersdorf Ag Desodorierende kosmetische mittel
DE4009347A1 (de) 1990-03-23 1991-09-26 Beiersdorf Ag Desodorierende kosmetische mittel
WO1992000706A1 (en) * 1990-07-03 1992-01-23 Bennett David Mervyn Penningto Tissue grafting
DE4204321A1 (de) 1992-02-13 1993-08-19 Beiersdorf Ag Verfahren zur isolierung und reinigung von fettsaeuren und hydroxyfettsaeuren und verwendungen von hydroxyfettsaeuren sowie zubereitungen, die sie enthalten
DE4229707A1 (de) 1992-09-05 1994-03-10 Beiersdorf Ag Germicide Wirkstoffkombinationen
DE4229737C2 (de) 1992-09-05 1996-04-25 Beiersdorf Ag Desodorierende kosmetische Mittel mit einem Gehalt an Fettsäuren
DE4237081C2 (de) 1992-11-03 1996-05-09 Beiersdorf Ag Verwendung von Di- oder Triglycerinestern als Deowirkstoffe
DE4309372C2 (de) 1993-03-23 1997-08-21 Beiersdorf Ag Kosmetische Desodorantien, enthaltend Gemische aus Wollwachssäuren oder Wollwachssäurekomponenten und Fettsäurepartialglyceriden unverzweigter Fettsäuren
DE4324219C2 (de) 1993-07-20 1995-08-10 Beiersdorf Ag Desodorierende Wirkstoffkombinationen auf der Basis von alpha, omega-Alkandicarbonsäuren und Wollwachssäuren
JP2858087B2 (ja) * 1994-09-19 1999-02-17 グンゼ株式会社 組織培養用基材及び組織培養法
DE10055940A1 (de) 2000-11-10 2002-05-29 Bayer Ag Neue Indanylidenverbindungen
DE10317400B4 (de) * 2003-04-15 2006-04-13 Universitätsklinikum Hamburg-Eppendorf EX-VIVO-Hautorganmodell aus Schweinehaut
DE10317402A1 (de) 2003-04-15 2004-11-11 Universitätsklinikum Hamburg-Eppendorf Ex-vivo-Hautorganmodell, insbesondere für männliche Haut
EP1927656A1 (de) * 2006-12-01 2008-06-04 Symrise GmbH & Co. KG Hautmodell

Also Published As

Publication number Publication date
EP2019316A3 (de) 2009-02-25
EP2019316B1 (de) 2011-05-11
US8278068B2 (en) 2012-10-02
US20090298113A1 (en) 2009-12-03
EP2019316A2 (de) 2009-01-28

Similar Documents

Publication Publication Date Title
ATE509095T1 (de) Menschliches ex-vivo-hautmodell
CO6311079A2 (es) Derivados de aminodihidrotiazina como inhibidores de la enzima bace para el tratamiento de la enfermedad de alzheimer
DOP2013000212A (es) Formas cristalinas del dimetoxi-docetaxel y sus procedimientos de preparacion
FR2939316B1 (fr) Utilisation cosmetique d'activateurs de l'autophagie des cellules cutanees.
FR2939033B1 (fr) Composition cosmetique de maquillage et/ou de soin des matieres keratiniques, et procede de maquillage
PL2640352T3 (pl) Hydrolizat kolagenu do zastosowania do poprawy zdrowia ludzkiej skóry, włosów i/lub paznokci
GT201100308A (es) Derivados de 1-(piperidin-4-il)-pirazol como moduladores de gpr 119
BRPI0810744A2 (pt) Moléculas absorventes de oxigênio, objetos que as contêm, e métodos de sua utilização
FR2916633B1 (fr) Utilisation cosmetique d'un actif capable de stimuler l'expression de la tensine 1
AU323701S (en) Medical instrument
ITBO20060735A1 (it) Calotta per il trattamento della pelle e del derma.
BRPI0813926A2 (pt) Utilização de uma substância, composição e métodos de triagem de princípios ativos que inibem a formação dos ages e de cuidado cosmético.
GB0819264D0 (en) Method and apparatus for the creation of a fine spray for applications related to air care:ambient scenting and personal care:cosmetic,skin and eye care
BRPI1007668A2 (pt) aparelho de medição do batimento cardíaco, uso do aparelho de medição do batimento cardíaco, método, adaptado para medir o batimento cardíaco e/ou a variação do batimento cardíaco de um indivíduo
EA201170672A1 (ru) Соединения, пригодные для лечения целлюлита
IT1394628B1 (it) Procedimento per un trattamento cosmetico anti-invecchiamento mediante stimolazione dell'espressione della survivina
UA110332C2 (en) Use of 2,3-dihydroxypropyldodecanoate for treatment of seborrhea
FR2927804B1 (fr) Procede cosmetique de soin de la peau.
FR2932986B1 (fr) Composition regeneratrice de la peau
WO2012065671A3 (de) Verwendung von ascorbinsäurederivaten zur färbung von keratinhaltigen fasern
FR2964868B1 (fr) Composition cosmetique aqueuse comprenant de l'alkylcellulose
ATE441408T1 (de) Zusammensetzung enthältend retinoid und beta- aminoisobuttersäurederivate
FR2900572B1 (fr) Procede cosmetique de soin de la peau utilisant des contraintes mecaniques
FR2943542B1 (fr) Methode de soin cosmetique anti-age par stimulation de l'activite de l'aconisate mitochondriale.
AR078904A1 (es) Enantiomero 4r,5s de 2-(5-metil-2-oxo-4-fenil-pirrolidin-1-il)-acetamida con actividad nootropica

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties